Comparative study between sugammadex and neostigmine

Not Applicable

• Conditions: Surgery; Paediatrics; neuromuscular blockade

• Registration Number: PACTR201511001296403
• Lead Sponsor: Minoufiya University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-06
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

American Society of Anesthesiologists (ASA) class I or II pediatric patients aged 2-10 years undergoing lower abdominal surgeries.

Exclusion Criteria

Body mass index more than 40 kg/m2,
liver or kidney disease,
history of malignant hyperthermia, neuromuscular disease,
history of hypersensitivity to any of the study drugs
and mental retardation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to reach TOF ratio greater than 0.90 wil be recorded;Number of patients needing another dose of sugammadex to reach TOF greater than 0.90;Extubation time

Secondary Outcome Measures

Name	Time	Method
Adverse events;Body temperature